Paul E. de Jong

38.2k citations

311 papers · 24.9k indexed · 9 hit papers · h-index 73

Nephrology top 0.01%
- Chronic Kidney Disease and Diabetes 115
- Dialysis and Renal Disease Management 83
- Renal Diseases and Glomerulopathies 32
Cardiology and Cardiovascular Medicine top 0.1%
- Blood Pressure and Hypertension Studies 90
- Renin-Angiotensin System Studies 29
Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments 17
Endocrinology, Diabetes and Metabolism top 0.1%
Pulmonary and Respiratory Medicine top 0.2%
- Renal and Vascular Pathologies 20
Nutrition and Dietetics
- Sodium Intake and Health 17

Co-authors: Dick de Zeeuw Ron T. Gansevoort Kunihiro Matsushita Josef Coresh Andrew S. Levey Brad C. Astor Hans L. Hillege Stephan J. L. Bakker
Cited by: Nephrology Cardiology and Cardiovascular Medicine Transplantation
Journals: Kidney International (39 papers)Nephrology Dialysis Transplantation (36 papers)American Journal of Kidney Diseases (20 papers)
Partner nations: Netherlands United States Pakistan

In The Last Decade

Paul E. de Jong

306 papers receiving 24.1k citations

Hit Papers

9 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2012 The Lancet
2011 Kidney International
2011 Kidney International
2010 Kidney International
2010 The Lancet
2004 Kidney International
2003 Annals of Internal Medicine
2002 Circulation
1996 New England Journal of Medicine

Peers

Countries citing papers authored by Paul E. de Jong

Since Specialization

Citations

This map shows the geographic impact of Paul E. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. de Jong more than expected).

Fields of papers citing papers by Paul E. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. de Jong. The network helps show where Paul E. de Jong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul E. de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul E. de Jong Line = papers co-authored together Paul E. de Jong links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function American Journal of Kidney Diseases ·Wendy E. Boertien,Esther Meijer,Paul E. de Jong,Gert J. Ter Horst,Remco J. Renken,Eric J. van der Jagt,Peter Kappert,John Ouyang,Gerwin E. Engels,Willem van Oeveren,Joachim Struck,Frank S. Czerwiec,Dorothee Oberdhan,Holly B. Krasa,Ron T. Gansevoort	2015	66
2	Association Between Sodium Intake and Change in Uric Acid, Urine Albumin Excretion, and the Risk of Developing Hypertension Circulation ·John P. Forman,Lieneke Scheven,Paul E. de Jong,Stephan J. L. Bakker,Gary C. Curhan,Ron T. Gansevoort	2012	77
3	Short-term change in kidney function and risk of end-stage renal disease Nephrology Dialysis Transplantation ·Tanvir Chowdhury Turin,Joseph Coresh,Marcello Tonelli,Paul E. Stevens,Paul E. de Jong,Chris Farmer,Thomas Helpin,Brenda R. Hemmelgarn	2012	83
4	Development and Validation of a General Population Renal Risk Score Clinical Journal of the American Society of Nephrology ·Nynke Halbesma,Désirée F. Jansen,Martijn W. Heymans,Ronald P. Stolk,Paul E. de Jong,Ronald T. Gansevoort	2011	65
5	N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Renal Transplant Recipients Versus the General Population Transplantation ·Leendert H. Oterdoom,Aiko P. J. de Vries,Rutger M. van Ree,Ron T. Gansevoort,Willem J. van Son,Jaap J. Homan van der Heide,Gerjan Navis,Paul E. de Jong,Rijk O. B. Gans,Stephan J. L. Bakker	2009	60
6	High Protein Intake Associates with Cardiovascular Events but not with Loss of Renal Function Journal of the American Society of Nephrology ·Nynke Halbesma,Stephan J. L. Bakker,Désirée F. Jansen,Ronald P. Stolk,Dick de Zeeuw,Paul E. de Jong,Ronald T. Gansevoort	2009	77
7	Apparent Loss of Urinary Albumin during Long-term Frozen Storage: HPLC vs Immunonephelometry Clinical Chemistry ·Jacoline Brinkman,Dick de Zeeuw,Hiddo J.L. Heerspink,Ronald T. Gansevoort,Ido P. Kema,Paul E. de Jong,Stephan J. L. Bakker	2007	34
8	Relative Blood Volume Changes Underestimate Total Blood Volume Changes during Hemodialysis Clinical Journal of the American Society of Nephrology ·Judith J. Dasselaar,Marjolijn N. Lub–de Hooge,Jan Pruim,Benny Seitzinger,林太郎奥野,Paul E. de Jong,Roel M. Huisman,Casper Franssen	2007	61
9	Pharmacoeconomics of Angiotensin II Antagonists in Type 2 Diabetic Patients with Nephropathy PharmacoEconomics ·Cornelis Boersma,Jarir At Thobari,Ron T. Gansevoort,Lolkje T.W. de Jong‐van den Berg,Paul E. de Jong,Dick de Zeeuw,Lieven Annemans,Maarten J. Postma	2006	21
10	Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients Nephrology Dialysis Transplantation ·Rutger M. van Ree,Leendert H. Oterdoom,Aiko P. J. de Vries,R. T. Gansevoort,J.J. Homan van der Heide,W.J. van Son,Rutger J. Ploeg,Paul E. de Jong,Rijk O. B. Gans,Stephan J. L. Bakker	2006	57
11	Social participation after successful kidney transplantation Disability and Rehabilitation ·Sijrike F. van der Mei,Abdalla A. Khoja,Willem J. van Son,Paul E. de Jong,Johan W. Groothoff,W.J.A. van den Heuvel	2006	30
12	The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population Kidney International ·Ron T. Gansevoort,Jacobien C. Verhave,Hans L. Hillege,Johannes G. M. Burgerhof,Stephan J. L. Bakker,Dick de Zeeuw,Paul E. de Jong	2005	127
13	The kidney, a cardiovascular risk marker, and a new target for therapy Kidney International ·Dick de Zeeuw,Hans L. Hillege,Paul E. de Jong	2005	94
14	Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. University of Groningen research database (University of Groningen / Centre for Information Technology) ·Jacobien C. Verhave,Ron T. Gansevoort,Hans L. Hillege,Dick de Zeeuw,Gary C. Curhan,Paul E. de Jong	2004	61
15	Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC Kidney International ·Jacoline Brinkman,Stephan J. L. Bakker,Ron T. Gansevoort,Hans L. Hillege,Ido P. Kema,Rijk O. B. Gans,Paul E. de Jong,Dick de Zeeuw	2004	64
16	1159-194 Cystatin C, a novel risk marker for mortality in the general population: Data obtained from the PREVEND study Journal of the American College of Cardiology ·Hans L. Hillege,Jacobien C. Verhave,Stephan J. L. Bakker,Ron T. Gansevoort,Dirk J. van Veldhuisen,Paul E. de Jong,Dick de Zeeuw	2004	2
17	C-reactive protein is associated with renal function abnormalities in a non-diabetic population Kidney International ·Erik M. Stuveling,Hans L. Hillege,Stephan J. L. Bakker,Rijk O. B. Gans,Paul E. de Jong,Dick de Zeeuw	2003	199
18	The importance of microalbuminuria as a cardiovascular risk indicator: A review. University of Groningen research database (University of Groningen / Centre for Information Technology) ·Gilles F.H. Diercks,Ad J. van Boven,Damayanthi Kanthilatha Edirisinghe,Paul E. de Jong,J L Rouleau,Wiek H. van Gilst	2002	60
19	The impact of antihypertensive drug groups on urinary albumin excretion in a non‐diabetic population British Journal of Clinical Pharmacology ·Taco B. M. Monster,Wilbert M.T. Janssen,Paul E. de Jong,Lolkje T.W. de Jong‐van den Berg,(unknown)	2002	13
20	Assessing dialysis adequacy and dietary intake in the individual hemodialysis patient Kidney International ·Endang Sri Novita,Coen A. Stegeman,E.J. van Kootwijk,Lylia Selila,Paul E. de Jong,Roel M. Huisman	1999	60

About Paul E. de Jong

Paul E. de Jong is a scholar working on Nephrology, Transplantation and Cardiology and Cardiovascular Medicine, having authored 311 papers that have together received 24.9k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (115 papers), Blood Pressure and Hypertension Studies (90 papers), Dialysis and Renal Disease Management (83 papers), Renal Diseases and Glomerulopathies (32 papers), Renin-Angiotensin System Studies (29 papers), Renal and Vascular Pathologies (20 papers), Sodium Intake and Health (17 papers) and Renal Transplantation Outcomes and Treatments (17 papers). The work is most often cited by research in Nephrology (13.0k citations), Cardiology and Cardiovascular Medicine (8.6k citations) and Transplantation (904 citations). Paul E. de Jong has collaborated with scholars based in Netherlands, United States and Pakistan. Frequent co-authors include Dick de Zeeuw, Ron T. Gansevoort, Kunihiro Matsushita, Josef Coresh, Andrew S. Levey, Brad C. Astor, Hans L. Hillege, Stephan J. L. Bakker, Mark Woodward and Marije van der Velde. Their work appears in journals such as Kidney International, Nephrology Dialysis Transplantation, American Journal of Kidney Diseases, Journal of the American Society of Nephrology and Clinical Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact